Viral ‘molecular scissor’ is next COVID-19 drug target
SAN ANTONIO, Texas, USA – American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel rationale for COVID-19 drug design – blocking a molecular “scissor” that the virus uses for virus production and to disable human proteins crucial to the immune response. The researchers are from The University of…